Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

1.

MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression.

Amirkhah R, Schmitz U, Linnebacher M, Wolkenhauer O, Farazmand A.

Genes Chromosomes Cancer. 2015 Mar;54(3):129-41. doi: 10.1002/gcc.22231.

PMID:
25620079
[PubMed - in process]
2.

Reactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.

Kuehn F, Klar E, Bliemeister A, Linnebacher M.

World J Gastroenterol. 2015 Jan 7;21(1):221-8. doi: 10.3748/wjg.v21.i1.221.

PMID:
25574094
[PubMed - in process]
Free PMC Article
3.

Establishment and characterization of cell lines from chromosomal instable colorectal cancer.

Maletzki C, Gock M, Randow M, Klar E, Huehns M, Prall F, Linnebacher M.

World J Gastroenterol. 2015 Jan 7;21(1):164-76. doi: 10.3748/wjg.v21.i1.164.

PMID:
25574089
[PubMed - in process]
Free PMC Article
4.

E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts.

Wiegering A, Korb D, Thalheimer A, Kämmerer U, Allmanritter J, Matthes N, Linnebacher M, Schlegel N, Klein I, Ergün S, Germer CT, Otto C.

Neoplasia. 2014 Nov 20;16(11):972-81. doi: 10.1016/j.neo.2014.09.008. eCollection 2014 Nov.

PMID:
25425971
[PubMed - in process]
Free PMC Article
5.

Biological and molecular effects of small molecule kinase inhibitors on low-passage human colorectal cancer cell lines.

Lange F, Franz B, Maletzki C, Linnebacher M, Hühns M, Jaster R.

Biomed Res Int. 2014;2014:568693. doi: 10.1155/2014/568693. Epub 2014 Sep 17.

PMID:
25309914
[PubMed - in process]
Free PMC Article
6.

Accounting for randomness in measurement and sampling in studying cancer cell population dynamics.

Ghavami S, Wolkenhauer O, Lahouti F, Ullah M, Linnebacher M.

IET Syst Biol. 2014 Oct;8(5):230-41. doi: 10.1049/iet-syb.2013.0031.

PMID:
25257023
[PubMed - in process]
7.

Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.

Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B.

Biochem Pharmacol. 2014 Nov 15;92(2):312-25. doi: 10.1016/j.bcp.2014.07.014. Epub 2014 Jul 25.

PMID:
25069049
[PubMed - in process]
8.

The impact of pyrvinium pamoate on colon cancer cell viability.

Wiegering A, Uthe FW, Hüttenrauch M, Mühling B, Linnebacher M, Krummenast F, Germer CT, Thalheimer A, Otto C.

Int J Colorectal Dis. 2014 Oct;29(10):1189-98. doi: 10.1007/s00384-014-1975-y. Epub 2014 Jul 26.

PMID:
25060218
[PubMed - in process]
9.

Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis.

Maletzki C, Klier U, Marinkovic S, Klar E, Andrä J, Linnebacher M.

Oncotarget. 2014 Jun 30;5(12):4467-79.

PMID:
24962950
[PubMed - in process]
Free PMC Article
10.

PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: two hits on the gene?

Hühns M, Salem T, Schneider B, Krohn M, Linnebacher M, Prall F.

Oncol Rep. 2014 May;31(5):2236-44. doi: 10.3892/or.2014.3097. Epub 2014 Mar 19.

PMID:
24647592
[PubMed - indexed for MEDLINE]
11.

Combinations of TLR ligands: a promising approach in cancer immunotherapy.

Stier S, Maletzki C, Klier U, Linnebacher M.

Clin Dev Immunol. 2013;2013:271246. doi: 10.1155/2013/271246. Epub 2013 Nov 25.

PMID:
24371445
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Microsatellite instability in hematological malignancies: Hypermutation vs. immune control-who is challenging who?

Maletzki C, Stier S, Linnebacher M.

Oncoimmunology. 2013 Aug 1;2(8):e25419. Epub 2013 Jul 1.

PMID:
24167765
[PubMed]
Free PMC Article
13.

Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: a detailed comparison.

Mullins CS, Schneider B, Stockhammer F, Krohn M, Classen CF, Linnebacher M.

PLoS One. 2013 Aug 7;8(8):e71070. doi: 10.1371/journal.pone.0071070. eCollection 2013.

PMID:
23951083
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.

Ramer R, Walther U, Borchert P, Laufer S, Linnebacher M, Hinz B.

J Lipid Res. 2013 Nov;54(11):3116-29. doi: 10.1194/jlr.M042283. Epub 2013 Aug 12.

PMID:
23943857
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy.

Maletzki C, Linnebacher M, Savai R, Hobohm U.

Cancer Immunol Immunother. 2013 Aug;62(8):1283-92. doi: 10.1007/s00262-013-1455-1. Epub 2013 Jul 6.

PMID:
23832140
[PubMed - indexed for MEDLINE]
16.

Cilengitide response in ultra-low passage glioblastoma cell lines: relation to molecular markers.

Mullins CS, Schubert J, Schneider B, Linnebacher M, Classen CF.

J Cancer Res Clin Oncol. 2013 Aug;139(8):1425-31. doi: 10.1007/s00432-013-1457-6. Epub 2013 Jun 8.

PMID:
23749036
[PubMed - indexed for MEDLINE]
17.

Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.

Maletzki C, Schmidt F, Dirks WG, Schmitt M, Linnebacher M.

Eur J Cancer. 2013 Jul;49(11):2587-95. doi: 10.1016/j.ejca.2013.02.035. Epub 2013 Apr 2.

PMID:
23561850
[PubMed - indexed for MEDLINE]
18.

Tumor-infiltrating B cells come into vogue.

Linnebacher M.

World J Gastroenterol. 2013 Jan 7;19(1):8-11. doi: 10.3748/wjg.v19.i1.8.

PMID:
23326156
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Establishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomas.

Maletzki C, Stier S, Gruenert U, Gock M, Ostwald C, Prall F, Linnebacher M.

PLoS One. 2012;7(12):e52485. doi: 10.1371/journal.pone.0052485. Epub 2012 Dec 31.

PMID:
23300683
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The "North German Tumor Bank of Colorectal Cancer": status report after the first 2 years of support by the German Cancer Aid Foundation.

Oberländer M, Linnebacher M, König A, Bogoevska V, Brodersen C, Kaatz R, Krohn M, Hackmann M, Ingenerf J, Christoph J, Mate S, Prokosch HU, Yekebas EF, Thorns C, Büning J, Prall F, Uhlig R, Roblick UJ, Izbicki JR, Klar E, Bruch HP, Vollmar B, Habermann JK; ColoNet consortium.

Langenbecks Arch Surg. 2013 Feb;398(2):251-8. doi: 10.1007/s00423-012-1043-4. Epub 2013 Jan 8.

PMID:
23292500
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk